Tokio Marine Asset Management CO LTD Bluebird Bio, Inc. Transaction History

Tokio Marine Asset Management CO LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$18.04 - $22.09 $313,896 - $384,366	-17,400 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $115,500 - $159,264	-4,200 Reduced 19.44%	17,400 $753,000
Q3 2020 Nov 09, 2020	SELL	$34.44 - $43.75 $10,332 - $13,125	-300 Reduced 1.37%	21,600 $1.17 Million
Q1 2020 May 12, 2020	BUY	$26.16 - $63.5 $117,720 - $285,750	4,500 Added 25.86%	21,900 $1.01 Million
Q3 2019 Oct 29, 2019	BUY	$59.47 - $93.1 $83,258 - $130,339	1,400 Added 8.75%	17,400 $1.6 Million

Q3 2018 Oct 23, 2018	BUY	$88.86 - $117.49 $17,772 - $23,498	200 Added 1.27%	16,000 $2.34 Million
Q2 2018 Jul 18, 2018	BUY	$99.64 - $127.59 $548,020 - $701,745	5,500 Added 53.4%	15,800 $2.48 Million
Q1 2018 May 03, 2018	BUY	$105.8 - $150.94 $1.09 Million - $1.55 Million	10,300 New	10,300 $1.76 Million

173

104M

827K

1.23M

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $75.6M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.